Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 3
1947 4
1948 2
1952 1
1953 2
1954 4
1956 2
1957 3
1958 3
1959 2
1961 2
1962 2
1963 2
1965 2
1967 2
1968 2
1969 1
1973 2
1974 3
1976 2
1977 3
1978 4
1979 1
1980 1
1981 1
1982 3
1983 3
1984 4
1985 1
1986 9
1987 3
1988 6
1989 4
1990 2
1991 9
1992 3
1993 10
1994 14
1995 24
1996 54
1997 120
1998 159
1999 146
2000 191
2001 259
2002 301
2003 329
2004 402
2005 407
2006 476
2007 553
2008 518
2009 575
2010 591
2011 578
2012 648
2013 615
2014 643
2015 669
2016 623
2017 585
2018 609
2019 687
2020 767
2021 716
2022 252
Text availability
Article attribute
Article type
Publication date

Search Results

11,281 results
Results by year
Filters applied: . Clear all
Page 1
Mechanisms of Botulinum Toxin Type A Action on Pain.
Matak I, Bölcskei K, Bach-Rojecky L, Helyes Z. Matak I, et al. Toxins (Basel). 2019 Aug 5;11(8):459. doi: 10.3390/toxins11080459. Toxins (Basel). 2019. PMID: 31387301 Free PMC article. Review.
Already a well-established treatment for different autonomic and movement disorders, the use of botulinum toxin type A (BoNT/A) in pain conditions is now continuously expanding. ...
Already a well-established treatment for different autonomic and movement disorders, the use of botulinum toxin type A …
Botulinum toxin type A therapy for cervical dystonia.
Castelão M, Marques RE, Duarte GS, Rodrigues FB, Ferreira J, Sampaio C, Moore AP, Costa J. Castelão M, et al. Cochrane Database Syst Rev. 2017 Dec 12;12(12):CD003633. doi: 10.1002/14651858.CD003633.pub3. Cochrane Database Syst Rev. 2017. PMID: 29230798 Free PMC article. Updated. Review.
Cervical dystonia is the most common form of focal dystonia and is a highly disabling movement disorder characterised by involuntary, usually painful, head posturing. Currently, botulinum toxin type A (BtA) is considered the first line therapy for this condit …
Cervical dystonia is the most common form of focal dystonia and is a highly disabling movement disorder characterised by involuntary, usuall …
Botulinum toxin type A for the treatment and prevention of hypertrophic scars and keloids: Updated review.
Kasyanju Carrero LM, Ma WW, Liu HF, Yin XF, Zhou BR. Kasyanju Carrero LM, et al. J Cosmet Dermatol. 2019 Feb;18(1):10-15. doi: 10.1111/jocd.12828. Epub 2018 Dec 12. J Cosmet Dermatol. 2019. PMID: 30548742 Review.
Botulinum Toxin Type A is a potent neurotoxin that is produced by a gram-positive bacteria clostridium botulinum. ...The aim of this review study was to show the role and mechanism of action of Botulinum toxin type A in the treatme …
Botulinum Toxin Type A is a potent neurotoxin that is produced by a gram-positive bacteria clostridium botulinum …
The efficiency of botulinum toxin type A for the treatment of masseter muscle pain in patients with temporomandibular joint dysfunction and tension-type headache.
Pihut M, Ferendiuk E, Szewczyk M, Kasprzyk K, Wieckiewicz M. Pihut M, et al. J Headache Pain. 2016;17:29. doi: 10.1186/s10194-016-0621-1. Epub 2016 Mar 24. J Headache Pain. 2016. PMID: 27011213 Free PMC article.
The purpose of the study was to assess the efficiency of intramuscular botulinum toxin type A injections for treating masseter muscle pain in patients with temporomandibular joint dysfunction and tension-type headache. METHODS: This prospective outcome …
The purpose of the study was to assess the efficiency of intramuscular botulinum toxin type A injections for treating m …
Migraine Treatment.
Olla D, Sawyer J, Sommer N, Moore JB 4th. Olla D, et al. Clin Plast Surg. 2020 Apr;47(2):295-303. doi: 10.1016/j.cps.2020.01.003. Epub 2020 Feb 6. Clin Plast Surg. 2020. PMID: 32115055 Review.
There are 4 types of migraine headaches: frontal, temporal, occipital, and rhinogenic. Each type has a well-described trigger site. Migraines headaches often are refractory to medical therapy and may respond well to botulinum toxin type A. ...
There are 4 types of migraine headaches: frontal, temporal, occipital, and rhinogenic. Each type has a well-described trigger site. M …
Botulinum toxin type A therapy for blepharospasm.
Duarte GS, Rodrigues FB, Marques RE, Castelão M, Ferreira J, Sampaio C, Moore AP, Costa J. Duarte GS, et al. Cochrane Database Syst Rev. 2020 Nov 19;11(11):CD004900. doi: 10.1002/14651858.CD004900.pub3. Cochrane Database Syst Rev. 2020. PMID: 33211907 Free PMC article.
It is a disabling disorder, characterised by chronic, intermittent or persistent, involuntary eyelid closure, due to spasmodic contractions of the orbicularis oculi muscles. Currently, botulinum toxin type A (BtA) is considered the first line of therapy for t …
It is a disabling disorder, characterised by chronic, intermittent or persistent, involuntary eyelid closure, due to spasmodic contractions …
Correction of overactive bladder with botulinum toxin type A (BTX-A).
Grishin A, Spaska A, Kayumova L. Grishin A, et al. Toxicon. 2021 Sep;200:96-101. doi: 10.1016/j.toxicon.2021.07.005. Epub 2021 Jul 15. Toxicon. 2021. PMID: 34274378
However, the duration of drug therapy is limited due to the frequent development of side effects. The study aimed to examine the efficacy of using botulinum toxin type A (BTX-A) in patients with overactive bladder. ...Patients in both groups underwent intrave …
However, the duration of drug therapy is limited due to the frequent development of side effects. The study aimed to examine the efficacy of …
Botulinum toxin type A for the treatment of lower urinary tract disorders.
Yokoyama T, Chancellor MB, Oguma K, Yamamoto Y, Suzuki T, Kumon H, Nagai A. Yokoyama T, et al. Int J Urol. 2012 Mar;19(3):202-15. doi: 10.1111/j.1442-2042.2011.02946.x. Epub 2012 Jan 6. Int J Urol. 2012. PMID: 22220916 Review.
Many papers report the clinical success of botulinum toxin A as a method of management of various bladder dysfunctions. The rationale was that botulinum toxin A was able to block the presynaptic release of acetylcholine from the parasympathetic efferen …
Many papers report the clinical success of botulinum toxin A as a method of management of various bladder dysfunctions. The ra …
Efficacy of radial extracorporeal shock wave therapy compared with botulinum toxin type A injection in treatment of lower extremity spasticity in subjects with cerebral palsy: A randomized, controlled, cross-over study.
Vidal X, Martí-Fàbregas J, Canet O, Roqué M, Morral A, Tur M, Schmitz C, Sitjà-Rabert M. Vidal X, et al. J Rehabil Med. 2020 Jun 30;52(6):jrm00076. doi: 10.2340/16501977-2703. J Rehabil Med. 2020. PMID: 32556354 Free article. Clinical Trial.
OBJECTIVES: To investigate whether botulinum toxin type A (BTX-A) injection is more effective than radial extracorporeal shock wave therapy in reducing plantar flexor muscle spasticity in subjects with cerebral palsy. ...
OBJECTIVES: To investigate whether botulinum toxin type A (BTX-A) injection is more effective than radial extracorporea …
Botulinum toxin type A in pregnancy.
Tan M, Kim E, Koren G, Bozzo P. Tan M, et al. Can Fam Physician. 2013 Nov;59(11):1183-4. Can Fam Physician. 2013. PMID: 24235190 Free PMC article.
QUESTION: My patient received 62 units of botulinum toxin type A (BTX-A) for facial lines. Two weeks later, she found out that she was pregnant. Will this cause any harm to her fetus? ANSWER: Botulinum toxin is not expected to be present in syst …
QUESTION: My patient received 62 units of botulinum toxin type A (BTX-A) for facial lines. Two weeks later, she found o …
11,281 results
You have reached the last available page of results. Please see the User Guide for more information.